Studies related to Body Fat and Saffron

Saffron And Crocin Improved Appetite, Dietary Intakes And Body Composition In Patients With Coronary Artery Disease

Effect Decrease
Values kg. Mean and SD. Placebo: before 25.26±5.52, after 25.23±5.63. Crocin: before 25.78±7.39, after 24.96±7.40. Saffron: before 26.61±4.23, after 25.06±4.42. %. Placebo: before 32.38±6.14, after 32.31±6.14. Crocin: before 32.29±7.60, after 31.58±7.66. Saffron: before 32.16±4.83, after 31.14±5.05.
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 84
Sex Both Genders
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 84 participants with coronary artery disease took an aqueous extract of 30 mg saffron, 30 mg of crocin, or placebo daily for 8 weeks.

There was a greater reduction in body weight, waist circumference, fat mass, and fat percentage, and fat-free mass in the saffron group compared with the others. The crocin group tended to see a greater reduction than the placebo group. The saffron group reported feeling less hungry and more satisfied overall.

There weren't meaningful differences for fasting glucose and lipid profile.

The trial was preregistered: IRCT201512102017N26

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.